Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D
Clinical trial NCT06649266 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06649266
- Sponsor
- Ribocure Pharmaceuticals AB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-21
- Primary completion
- 2026-09-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.